Optimal treatment allocation and study duration for trials with discrete-time survival endpoints
From MaRDI portal
Publication:1937208
DOI10.1016/j.jspi.2012.11.006zbMath1257.62105OpenAlexW1976422621MaRDI QIDQ1937208
Mirjam Moerbeek, Katarzyna Jóźwiak
Publication date: 28 February 2013
Published in: Journal of Statistical Planning and Inference (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jspi.2012.11.006
Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Generalized linear models (logistic models) (62J12)
Related Items (2)
Optimal designs for discrete-time survival models with random effects ⋮ D‐optimal designs for a continuous predictor in longitudinal trials with discrete‐time survival endpoints
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Cost-effective designs for trials with discrete-time survival endpoints
- Maximind-optimal designs for binary longitudinal responses
- Efficiency of Balanced Treatment Allocation for Survival Analysis
- An Introduction to Optimal Designs for Social and Biomedical Research
- Sample Sizes for Clinical Trials
- Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification
- On Robust and Efficient Designs for Risk Estimation in Epidemiological Studies
- Sample Size Calculations in Clinical Research
- Survival Analysis
This page was built for publication: Optimal treatment allocation and study duration for trials with discrete-time survival endpoints